Anomaly Insights, an AI-powered payer intelligence company, announced Wednesday that it raised $17 million in funding. The company’s platform analyzes healthcare transactions to identify payer ...

The Trump administration’s crackdown on fraud, waste and abuse continues, with the Department of Justice last week launching a new effort targeting healthcare fraud. Experts think the new strike force ...

IKS Health, a Dallas-based company that sells software to healthcare providers, acquired ARAI this week to deepen its agentic AI infrastructure and decrease its reliance on third-party AI models. The ...

On Wednesday, the Centers for Medicare & Medicaid Services implemented a six-month moratorium on new Medicare enrollment for hospices and home health agencies. The moratorium seeks to temporarily stop ...

The high cost of GLP-1s is causing some employers to reconsider their coverage, a new survey from the Business Group on Health found. The survey received responses from 105 self-funded employers. It ...

MedCity News has long covered innovation in healthcare. We have also hosted events bringing together investors, startups and the healthcare ecosystem in a bid to connect those novel companies to ...

For biopharma companies, designing therapies with elderly patients in mind is no longer a nice-to-have — it’s a clear business imperative. As we all know, adults over 65 represent one of the ...

Disagreements between providers and payers have been moving into the courtroom over the past few weeks. The California ...

When a biotech startup reveals a substantial round of funding, the announcement typically includes information about a pipeline, or at least a lead drug candidate. Large sums are also often a sign of ...

Sanford Health, known for being the nation’s largest rural health system, has announced plans to grow its footprint even further and establish a presence in Minnesota’s Twin Cities. The organization ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized rare disease products and entry into the U.S.

Social comments show how patients, caregivers, and HCPs interpret your content in real time. They reveal where questions keep surfacing, where misinformation starts to take hold, and how people ...